Guobang Pharma Ltd. (605507.SH) has accumulated repurchased 1.04% of its shares, spending 112 million yuan.
Guobang Pharmaceutical (605507.SH) announced that as of November 18, 2025, the company has completed trading through centralized auction.
Announcement from Guobang Pharma Ltd. (605507.SH): As of November 18, 2025, the company has repurchased a total of 5.7866 million shares through centralized auction trading, representing 1.04% of the total share capital. The total amount paid for the repurchase is 112 million yuan (excluding transaction fees).
Related Articles

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.

Yiwu Huading Nylon (601113.SH) shareholders in Yiwu Economic Development Zone plan to transfer up to 6% of their shares through public solicitation.
Crown Advanced Material (688560.SH) terminates investment agreement with CECEP Solar Energy for backsheet and functional film production base project.
Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.

Yiwu Huading Nylon (601113.SH) shareholders in Yiwu Economic Development Zone plan to transfer up to 6% of their shares through public solicitation.

Crown Advanced Material (688560.SH) terminates investment agreement with CECEP Solar Energy for backsheet and functional film production base project.
RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


